Cumberland Pharmaceuticals Inc.
CPIX
$2.79
-$0.01-0.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 15.21% | -23.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 64.95% | -23.48% | |||
| Cost of Revenue | 126.67% | -50.84% | |||
| Gross Profit | 56.60% | -17.25% | |||
| SG&A Expenses | 46.24% | -1.31% | |||
| Depreciation & Amortization | 0.36% | 0.31% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 46.72% | -11.46% | |||
| Operating Income | 30.23% | -162.92% | |||
| Income Before Tax | 27.68% | -166.40% | |||
| Income Tax Expenses | 307.02% | 0.00% | |||
| Earnings from Continuing Operations | 26.70% | -165.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 104.82% | 250.91% | |||
| Net Income | 27.26% | -162.02% | |||
| EBIT | 30.23% | -162.92% | |||
| EBITDA | 64.50% | -423.85% | |||
| EPS Basic | 27.22% | -162.02% | |||
| Normalized Basic EPS | 28.54% | -161.69% | |||
| EPS Diluted | 27.38% | -160.00% | |||
| Normalized Diluted EPS | 28.54% | -161.69% | |||
| Average Basic Shares Outstanding | -0.01% | -0.01% | |||
| Average Diluted Shares Outstanding | -0.01% | -0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||